Dipeptidyl-peptidase IV inhibitor-associated bullous pemphigoid efficiently treated with omalizumab

Dermatol Ther. 2020 Nov;33(6):e14160. doi: 10.1111/dth.14160. Epub 2020 Sep 6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Dipeptidyl-Peptidase IV Inhibitors* / adverse effects
  • Humans
  • Hypoglycemic Agents
  • Non-Fibrillar Collagens
  • Omalizumab / adverse effects
  • Pemphigoid, Bullous* / chemically induced
  • Pemphigoid, Bullous* / diagnosis
  • Pemphigoid, Bullous* / drug therapy

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Hypoglycemic Agents
  • Non-Fibrillar Collagens
  • Omalizumab